Opko Health Inc (OPK)

R&D Expense Growth

13.59%

Quarterly · Period ending:

OPK logo

OPK R&D Expense Growth

Latest reported13.59%
OPK Quarterly R&D Growth (QoQ) (0.00% → 13.59%)
High-resolution chart · PNG

OPK r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Opko Health Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
13.5861%
-10.9026%
8.9567%
-0.8701%
-1.618%
1.3673%
5.7525%
19.4668%
9.778%
13.0773%
-0.1801%
7.0268%
-44.3061%
66.9654%
3.9166%
8.9139%
-5.7776%
-12.8291%
14.7547%
0.461%
-5.6588%
10.3714%
-5.3696%
5.0261%
-19.0809%
-5.5474%
-23.2502%
6.1196%
-23.4438%
10.955%
7.4194%
6.1244%
-11.2128%
-3.8012%
5.7874%
-2.4119%
24.743%
-3.779%
10.2985%
-21.8398%
15.0708%
9.2001%
34.5408%
-37.0048%
15.7572%
0.5498%
25.881%
26.3829%
-22.6731%
-10.0899%
110.645%
15.9883%
-3.5621%
60.6159%
70.3949%
-19.3541%
-7.0586%
13.537%
28.9003%
21.8981%
148.8971%
-62.5731%
88.3992%
-2.0317%
18.5994%
-30.7973%
-31.5865%
12.2898%
-55.8579%
-16.9504%
38.6933%
-10.3304%
25.7805%
13.4375%
185.4093%
-182.7383%
-10.5072%
0%
-100%
0%
-100%
0%
0%
0%
0%
100%
0%
-100%
0%
0%
0%
-100%
-73.7705%
-81.1437%
-21.4806%
-34.2903%
1.0475%
2.6468%
9.3128%
-40.4736%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.